Top
| Implication of pituitary tropic status on tumor development | p. 1 |
| Anterior pituitary cell renewal during the estrous cycle | p. 9 |
| Bone morphogenetic protein-4 control of pituitary pathophysiology | p. 22 |
| Genesis of prolactinomas : studies using estrogen-treated animals | p. 32 |
| Dopaminergic D2 receptor knockout mouse : an animal model of prolactinoma | p. 50 |
| Vasoinhibins : a family of N-terminal prolactin fragments that inhibit angiogenesis and vascular function | p. 64 |
| Molecular mechanisms of pituitary differentiation and regulation : implications for hormone deficiencies and hormone resistance syndromes | p. 74 |
| Long-term follow-up of prolactinomas : should dopamine agonist treatment be life-long? | p. 88 |
| Ghrelin : from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions | p. 102 |
| Regulating of growth hormone sensitivity by sex steroids : implications for therapy | p. 115 |
| Acromegaly : molecular expression of somatostatin receptor subtypes and treatment outcome | p. 129 |
| Gene therapy in the neuroendocrine system | p. 135 |
| Ectopic ACTH syndrome | p. 143 |
| Estrogens and neuroendocrine hypothalamic-pituitary-adrenal axis function | p. 157 |
| New aspects in the diagnosis and treatment of cushing disease | p. 169 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
